Decision letter for "Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Glargine 100 U/mL in Asia Pacific Insulin‐Naïve People with Type 2 Diabetes: The EDITION AP Randomised Controlled Trial"
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
2019 ◽
Vol 7
(11)
◽
pp. 834-844
◽
2019 ◽
2019 ◽